CLINICAL_TRIALS
withdrawal
· 2025-12-12
Clinical Trial Update: Patient-specific, Effective, and Rational Functional Connectivity Targeting for DBS in OCD
Summary
A clinical trial evaluating patient-specific functional connectivity targeting for deep brain stimulation in obsessive-compulsive disorder has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Obsessive-Compulsive Disorder | Status: WITHDRAWN